Onyx Pharma (ONXX) calls active on positive Nexavar Phase 2 data
Tweet Send to a Friend
Onyx Pharma (Nasdaq: ONXX) is recently up $6.74 to $35.43. ONXX and Bayer Healthcare said that their first ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
